Abstract
Adjuvant selection in vaccines is a key to induce potent immune responses. The current licensed adjuvant alum is found to be insufficient to induce cellular immune responses and a balanced Th1/Th2 ...
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have